TY - JOUR
T1 - Characterization of SETD3 methyltransferase-mediated protein methionine methylation
AU - Dai, Shaobo
AU - Holt, Matthew V.
AU - Horton, John R.
AU - Woodcock, Clayton B.
AU - Patel, Anamika
AU - Zhang, Xing
AU - Young, Nicolas L.
AU - Wilkinson, Alex W.
AU - Cheng, Xiaodong
N1 - Funding Information:
Funding and additional information—This work was supported by National Institutes of Health Grants R35GM134744 and CPRIT RR160029 (to X. C.) and R01GM133051 (to A. W. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding Information:
Acknowledgments—We thank Da Jia for purification of SET7 used for activity assays, members of the Cheng laboratory for discussion, and Dr. Or Gozani (Stanford University) for support under National Institutes of Health Grant R01 GM133051.
Publisher Copyright:
© 2020 Dai et al. Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2020/8/7
Y1 - 2020/8/7
N2 - Most characterized protein methylation events encompass arginine and lysine N-methylation, and only a few cases of protein methionine thiomethylation have been reported. Newly discovered oncohistone mutations include lysine-to-methionine substitutions at positions 27 and 36 of histone H3.3. In these instances, the methionine substitution localizes to the active-site pocket of the corresponding histone lysine methyltransferase, thereby inhibiting the respective transmethylation activity. SET domain-containing 3 (SETD3) is a protein (i.e. actin) histidine methyltransferase. Here, we generated an actin variant in which the histidine target of SETD3 was substituted with methionine. As for previously characterized histone SET domain proteins, the methionine substitution substantially (76-fold) increased binding affinity for SETD3 and inhibited SETD3 activity on histidine. Unexpectedly, SETD3 was active on the substituted methionine, generating S-methylmethionine in the context of actin peptide. The ternary structure of SETD3 in complex with the methionine-containing actin peptide at 1.9 Å resolution revealed that the hydrophobic thioether side chain is packed by the aromatic rings of Tyr312 and Trp273, as well as the hydrocarbon side chain of Ile310. Our results suggest that placing methionine properly in the active site-within close proximity to and in line with the incoming methyl group of SAM-would allow some SET domain proteins to selectively methylate methionine in proteins.
AB - Most characterized protein methylation events encompass arginine and lysine N-methylation, and only a few cases of protein methionine thiomethylation have been reported. Newly discovered oncohistone mutations include lysine-to-methionine substitutions at positions 27 and 36 of histone H3.3. In these instances, the methionine substitution localizes to the active-site pocket of the corresponding histone lysine methyltransferase, thereby inhibiting the respective transmethylation activity. SET domain-containing 3 (SETD3) is a protein (i.e. actin) histidine methyltransferase. Here, we generated an actin variant in which the histidine target of SETD3 was substituted with methionine. As for previously characterized histone SET domain proteins, the methionine substitution substantially (76-fold) increased binding affinity for SETD3 and inhibited SETD3 activity on histidine. Unexpectedly, SETD3 was active on the substituted methionine, generating S-methylmethionine in the context of actin peptide. The ternary structure of SETD3 in complex with the methionine-containing actin peptide at 1.9 Å resolution revealed that the hydrophobic thioether side chain is packed by the aromatic rings of Tyr312 and Trp273, as well as the hydrocarbon side chain of Ile310. Our results suggest that placing methionine properly in the active site-within close proximity to and in line with the incoming methyl group of SAM-would allow some SET domain proteins to selectively methylate methionine in proteins.
UR - http://www.scopus.com/inward/record.url?scp=85089301710&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089301710&partnerID=8YFLogxK
U2 - 10.1074/jbc.ra120.014072
DO - 10.1074/jbc.ra120.014072
M3 - Article
C2 - 32503840
AN - SCOPUS:85089301710
SN - 0021-9258
VL - 295
SP - 10901
EP - 10910
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 32
ER -